Given the regulatory effect of CAND1 on lipid accumulation in female mice and AR-negative cell lines (THLE-2 and HepG2), there may be other pathways regulating CAND1 expression and involved in the development of NAFLD in female mice. This evidence concerns the gene CAND1 and metabolic dysfunction-associated steatotic liver disease.